Šalis: Jungtinės Valstijos
kalba: anglų
Šaltinis: NLM (National Library of Medicine)
CHITOSAN OLIGOSACCHARIDE (UNII: 23R93M6Y64) (CHITOSAN OLIGOSACCHARIDE - UNII:23R93M6Y64)
38 Biotech Laboratory LLC
NASAL
OTC DRUG
unapproved homeopathic
CHITOPREX 101- 38 BIOTECH LABORATORY LLC CAPSULE 38 BIOTECH LABORATORY LLC _Disclaimer: This homeopathic product has not been evaluated by the Food and Drug Administration for_ _safety or efficacy. FDA is not aware of scientific evidence to support homeopathy as effective._ ---------- CHITOPREX DOSAGE & ADMINISTRATION CHITOPREX 101 38 biotech laboratory llc capsule PRODUCT INFORMATION PRODUCT T YPE HUMAN OTC DRUG ITE M COD E (S OURCE ) NDC:6 9 573- 8 8 8 ROUTE OF ADMINISTRATION NASAL, INTRATUMOR, IRRIGATION, INTRAVENOUS, ORAL, PERIODONTAL, INTRAOCULAR, RECTAL, SUBLINGUAL, TOPICAL, TRANSDERMAL, VAGINAL, URETERAL, DENTAL ACTIVE INGREDIENT/ACTIVE MOIETY INGREDIENT NAME BASIS OF STRENGTH STRE NG TH CHITO SAN O LIGO SACCHARIDE (UNII: 23R9 3M6 Y6 4) (CHITOSAN OLIGOSACCHARIDE - UNII:23R9 3M6 Y6 4) CHITOSAN HIGH MOLECULAR WEIGHT (8 0 0 -20 0 0 MPA.S) 250 mg in 250 mg INACTIVE INGREDIENTS INGREDIENT NAME STRE NG TH NO RI (UNII: 477TV3P5UX) 250 mg in 250 mg PRODUCT CHARACTERISTICS COLOR bro wn (wet bro wn sugar like) S CORE sco re with uneven pieces S HAP E CAPSULE (40 0 mg) S IZ E 1mm FLAVOR CHICKEN IMPRINT CODE 1 CONTAINS PACKAG ING # ITEM CODE PACKAGE DESCRIPTION MARKETING START DATE MARKETING END DATE 1 NDC:6 9 573-8 8 8 -33 30 in 1 BOTTLE 0 5/16 /20 15 1 NDC:6 9 573-8 8 8 -11 50 0 mg in 1 CAPSULE; Type 0 : No t a Co mbinatio n Pro duct MARKETING INFORMATION MARKE TING CATE GORY APPLICATION NUMBE R OR MONOGRAPH CITATION MARKE TING START DATE MARKE TING END DATE unappro ved ho meo pathic 0 2/27/20 15 38 Biotech Laboratory LLC LABELER - 38 Biotech Laboratory LLC (079677339) ESTABLISHMENT NAME AD D RE S S ID/FEI BUSINE SS OPE RATIONS 38 Bio tech Labo rato ry LLC 0 79 6 77339 ma nufa c ture (6 9 573-8 8 8 ) Revised: 2/2015 Perskaitykite visą dokumentą